RAUDENSKÁ, Martina, Monika KRATOCHVÍLOVÁ, Tomáš VIČAR, Jaromír GUMULEC, Jan BALVAN, Hana POLANSKÁ, Jan PŘIBYL and Michal MASAŘÍK. Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation. Scientific reports. London: NATURE PUBLISHING GROUP, 2019, vol. 9, No 1660, p. 1-11. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-018-38199-7.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation
Authors RAUDENSKÁ, Martina (203 Czech Republic, belonging to the institution), Monika KRATOCHVÍLOVÁ (203 Czech Republic, belonging to the institution), Tomáš VIČAR (203 Czech Republic, belonging to the institution), Jaromír GUMULEC (203 Czech Republic, belonging to the institution), Jan BALVAN (203 Czech Republic, belonging to the institution), Hana POLANSKÁ (203 Czech Republic, belonging to the institution), Jan PŘIBYL (203 Czech Republic, belonging to the institution) and Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution).
Edition Scientific reports, London, NATURE PUBLISHING GROUP, 2019, 2045-2322.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30105 Physiology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.998
RIV identification code RIV/00216224:14110/19:00107357
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1038/s41598-018-38199-7
UT WoS 000458017800128
Keywords in English prostate cancer cells
Tags 14110515, 14110518, CF NANO, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 4/3/2020 15:33.
Abstract
We focused on the biomechanical and morphological characteristics of prostate cancer cells and their changes resulting from the effect of docetaxel, cisplatin, and long-term zinc supplementation. Cell population surviving the treatment was characterized as follows: cell stiffness was assessed by atomic force microscopy, cell motility and invasion capacity were determined by colony forming assay, wound healing assay, coherence-controlled holographic microscopy, and real-time cell analysis. Cells of metastatic origin exhibited lower height than cells derived from the primary tumour. Cell dry mass and CAV1 gene expression followed similar trends as cell stiffness. Docetaxel-and cisplatin-surviving cells had higher stiffness, and decreased motility and invasive potential as compared to non-treated cells. This effect was not observed in zinc(II)-treated cells. We presume that cell stiffness changes may represent an important overlooked effect of cisplatin-based anti-cancer drugs. Atomic force microscopy and confocal microscopy data images used in our study are available for download in the Zenodo repository.
Links
GA18-24089S, research and development projectName: Kvantitativní fázová mikroskopie pro 3D kvalitativní charakterizaci nádorových buněk
Investor: Czech Science Foundation
LM2015043, research and development projectName: Česká infrastruktura pro integrativní strukturní biologii (Acronym: CIISB)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1553/2018, interní kód MUName: Genetické, environmentální a tkáňové charakteristiky vybraných patologických stavů a nemocí (Acronym: genetika; stres; biomateriály; tkáňové kultury)
Investor: Masaryk University, Category A
ROZV/24/LF/2018, interní kód MUName: LF - Příspěvek na IP 2108
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
PrintDisplayed: 1/5/2024 02:09